Literature DB >> 9379386

Intraocular lens position and anterior chamber angle changes after cataract extraction in eyes with primary angle-closure glaucoma.

C H Yang1, P T Hung.   

Abstract

PURPOSE: To prospectively study the anterior chamber angle in eyes with chronic primary angle-closure glaucoma (PACG) having posterior chamber intraocular lens (IOL) implantation and evaluate IOL position and intraocular pressure (IOP).
SETTING: National Taiwan University Hospital, Taipei, Taiwan.
METHODS: Using Scheimpflug image processing, the anterior chamber angles were studied in 20 consecutive eyes with chronic PACG and 10 control eyes before and after posterior chamber IOL implantation. Anterior chamber depth, chamber angle width, IOL position, and IOP change were evaluated.
RESULTS: Mean anterior chamber depth in the PACG group was 2.04 +/- 0.29 mm preoperatively and 3.44 +/- 0.16 mm postoperatively. The anterior chamber angle widened significantly in relation to the superior, inferior, temporal, and nasal quadrants after surgery. The degree of IOL tilting and decentration was the same in both the PACG and control groups. All eyes in the PACG group maintained an IOP under 21 mm Hg during the 6 month follow-up. Eighty-four percent maintained or decreased their antiglaucoma medication; 16% required increased medication.
CONCLUSION: Cataract extraction with posterior chamber IOL implantation in eyes with PACG controlled IOP well in most cases.

Entities:  

Mesh:

Year:  1997        PMID: 9379386     DOI: 10.1016/s0886-3350(97)80089-2

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  17 in total

1.  Effects of phacoemulsification surgery on ocular hemodynamics.

Authors:  Adem Turk; Suleyman Mollamehmetoglu; Halil Ibrahim Imamoglu; Mehmet Kola; Hidayet Erdol; Nurettin Akyol
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

Review 2.  [Primary phacoemulsification following acute primary angle closure glaucoma].

Authors:  P C Jacobi
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

3.  Factors affecting refractive outcome after cataract surgery in patients with a history of acute primary angle closure.

Authors:  Hyo Seok Lee; Jung Won Park; Sang Woo Park
Journal:  Jpn J Ophthalmol       Date:  2013-10-29       Impact factor: 2.447

4.  Optical coherence tomography angiography evaluation of the effects of phacoemulsification cataract surgery on macular hemodynamics in Chinese normal eyes.

Authors:  Xinyu Jia; Yinjuan Wei; Hui Song
Journal:  Int Ophthalmol       Date:  2021-08-04       Impact factor: 2.031

5.  [Cataract extraction including posterior chamber lens implantation in the treatment of acute glaucoma].

Authors:  H Bleckmann; R Keuch
Journal:  Ophthalmologe       Date:  2006-03       Impact factor: 1.059

Review 6.  Lens extraction for chronic angle-closure glaucoma.

Authors:  D S Friedman; S S Vedula
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

7.  Intermediate results of phaco-endocycloplasty in an exclusive cohort of angle closure glaucoma: potential for change.

Authors:  Vanita Pathak-Ray
Journal:  Int Ophthalmol       Date:  2019-01-03       Impact factor: 2.031

Review 8.  Has the EAGLE landed for the use of clear lens extraction in angle-closure glaucoma? And how should primary angle-closure suspects be treated?

Authors:  Luke Tanner; Gus Gazzard; Winifred P Nolan; Paul J Foster
Journal:  Eye (Lond)       Date:  2019-10-24       Impact factor: 3.775

9.  Primary phacoemulsification and intraocular lens implantation for acute primary angle-closure.

Authors:  Wei-Wen Su; Phil Yeong-Fung Chen; Ching-Hsi Hsiao; Henry Shen-Lih Chen
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

10.  Inaccuracy of intraocular lens power prediction for cataract surgery in angle-closure glaucoma.

Authors:  Sung Yong Kang; Samin Hong; Jung Bin Won; Gong Je Seong; Chan Yun Kim
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.